Eduardo Munhoz
Eduardo Munhoz publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #3,586,463 of 7,710,434 ranked researchers
- Rank in Brazil
- #48,260 of 253,246
- Works
- 23
- Citations
- 325
- Citations per work
- 14.1
What does Eduardo Munhoz research?
Eduardo Munhoz's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1460.0%
- Medicine1460.0%
- Everything else627.7%
- Life Sciences312.3%
- 1Hematology23% of their works
- 2Genetics14% of their works
- 3Molecular Biology12% of their works
- 4Pathology and Forensic Medicine11% of their works
- 5Radiology, Nuclear Medicine and Imaging8% of their works
- 6Public Health, Environmental and Occupational Health5% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Advanced biosensing and bioanalysis techniques
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Eduardo Munhoz's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Classification, Genomic Aberrations and Lymphoma.
- Self-Assembly
- JAK2 Mutation
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Therapeutic Antibodies
- Lymphoma
- Classification
- Imatinib
- Prognostic Factors
- Rituximab
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Fc Receptors
- AML
- Acute Myeloid Leukemia
- DNA nanotechnology
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab142 topics
- Prognostic Factors133 topics
- BCR-ABL91 topic
- Imatinib91 topic
- Chronic Lymphocytic Leukemia71 topic
- Classification71 topic
- Genomic Aberrations71 topic
- Lymphoma71 topic
- Fc Receptors51 topic
- Therapeutic Antibodies51 topic
- AML31 topic
- Acute Lymphoblastic Leukemia31 topic
- Acute Myeloid Leukemia31 topic
- Childhood Cancer31 topic
- DNA nanotechnology21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
- Self-Assembly21 topic
Where does Eduardo Munhoz work?
Eduardo Munhoz's main affiliation in the publication record is Hospital Erasto Gaertner, Brazil.
How many publications and citations does Eduardo Munhoz have?
OpenAlex counts 23 works and 325 citations for Eduardo Munhoz, an h-index of 7, ranking #3,586,463 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eduardo Munhoz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.